Second thoughts about implementing routine screening of cancer patients for distress by Coyne, J. C.
  
 University of Groningen






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Final author's version (accepted by publisher, after peer review)
Publication date:
2013
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Coyne, J. C. (2013). Second thoughts about implementing routine screening of cancer patients for distress.
Psycho Oncologie, 7(4), 243-249. https://doi.org/10.1007/s11839-013-0437-z
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019







Second Thoughts About Implementing Routine Screening of Cancer Patients for Distress 
 
James C. Coyne, PhD. 
University Medical Center, Groningen, the Netherlands 
and  
Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of 






James C. Coyne 
University of Groningen, University Medical Centre Groningen 
Department of Health Sciences, Health Psychology Section 
P.O. Box 196 
9700 AD Groningen 
The Netherlands 
Email: jcoynester@gmail.com 
Published in French: Coyne JC. Second thoughts about implementing routine screening of 
cancer patients for distress. Psycho-Oncologie. 2013 Dec 1;7(4):243-9. 
 
  






Recommendations for routine screening of cancer patients for distress lack evidence 
screening improves patient outcomes. Settings contemplating screening should consider other 
options for using the same resources. This article reviews evidence relevant to decision 
making and calls attention to limits in using screening instruments cross-culturally and for 
triaging patients for receipt of services. Whether screening is the best option depends on the 
patient population, culture and health system. 
  






National and international professional organizations recommend and increasingly 
mandate routine screening of cancer patients for distress [1-4]. Professionals in many 
oncology settings are attempting to comply by implementing screening programs. In other 
settings, professionals are allowed to consider first whether available evidence is consistent 
with screening actually improving patient outcomes. They can decide whether to proceed with 
implementing screening or to find other ways to commit the resources that screening would 
require. In either case, clinicians, administrators, and policy makers do not have the benefit of 
a substantial body of evidence from randomized controlled trials demonstrating that routine 
screening for distress will lead to improved patient outcomes [5].  
How to Evaluate the Evidence for the Efficacy of Screening  
Screening for medical conditions is commonplace in clinical settings [6], and there are 
specific methodologies for evaluating the efficacy and cost effectiveness of screening for 
particular problems [7,8]. There was once a general assumption that clinicians should 
routinely screen if a means existed for problems that have significant clinical and public health 
implications. That conventional wisdom has undergone serious re-evaluation with the 
recognition that consultations with clinicians cannot accommodate screening for all problems. 
Moreover, much screening reveals problems for which intervention would not even be 
practical, cost-effective, or consistent with patient preferences. Screening can also lead to 
needless diagnostic and follow up procedures, overdiagnosis and overtreatment, with any 
benefits not balancing known drawbacks or even harm.  
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Attitudes toward screening vary greatly across cultures and health systems, with an 
extreme captured by direct-to-consumer marketing in North America of comprehensive 
computed tomography (CT) scans on demand to asymptomatic persons based on their ability 
to pay [9]. In response to such excesses, Choosing Wisely programs [10] have been endorsed 
by dozens of specialty and generalist medical societies to encourage re-evaluations of the 
efficacy and cost effectiveness of screening. This has led to recommendations against 
screening asymptomatic persons for dementia and ovarian, lung, and prostate cancer. 
Recommendations for routine screening require demonstration that screening has a better 
balance of benefits and potential harm at the patient and system level than patients simply 
having access to the same clinical resources without having to undergo screening. The 
burden of proof is on those who would recommend screening. 
More than simply targeting an important clinical problem, screening must lead to 
improvement in patient outcomes. Thus, the World Health Organization recently advised that 
screening for intimate partner violence in general medical settings should no longer be done, 
because it did not lead to improved outcomes [11].  Routine screening for depression had 
previously been recommended and mandated in many general and specialty medical settings 
[12]. But when formally reevaluated, recommendations were next restricted in some countries 
to settings where resources are available for adequate diagnosis, treatment, and follow-up 
[13].  More recently, screening for depression is no longer being recommended except for 
settings with the necessary resources to ensure improved outcomes, with the presumption 
such settings are uncommon [14]. These revised recommendations are based on consistent 
evidence that without exceptional resources, routine screening for depression was not 
improving patient outcomes, and that where these resources are available, screening may 
add nothing to patient outcomes [15]. 
Is There Evidence That Screening for Distress Improves Patient Outcomes? 
Implementing Screening for Distress 
5 
 
We undertook a systematic review of screening for routine distress in cancer patients [5], 
cognizant of the general standards used for evaluating screening in medical settings. We 
adopted the analytic framework of the U.S. Preventive Services Task Force (USPSTF) [16] in 
searching for evidence of (1) the efficacy of interventions for reducing distress; and (2) the 
efficacy of routine screening in reducing distress among cancer patients. For the first question 
we concluded that there is indeed some evidence that psychosocial and 
psychopharmacological interventions reduce distress. In answering the second question, we 
required randomized trials with patients assigned to the intervention receiving services based 
on score above a pre-set score on a screening instrument, whereas patients assigned to the 
control group could access the services without screening. We were able to identify only one 
such study [17] and it failed to demonstrate that screening improved outcomes. We concluded 
that, judged by established standards, there is insufficient evidence to recommend screening. 
At least four other systematic reviews [18-21] have considered routine screening for 
distress. None adopted the same inclusion criteria as we did, with all considering a broader 
range of studies. The authors of all four included recognizable advocates of screening, but all 
nonetheless indicated a lack of quality evidence from randomized trials that screening 
improves patient outcomes. Yet, each review provided detailed guidance on how to implement 
distress screening in clinical practice. One review [21] concluded:  
Provisional work suggests that screening for psychological distress holds promise and 
is often clinically valuable, but it is too early to conclude definitively that psychological 
screening itself affects the psychological well-being of cancer patients. 
The reviews variously indicated that screening may improve communication between 
patients and clinicians, stimulate discussions of psychosocial and mental health issues, and 
increase referrals to specialty services.  These are not suitable surrogate outcomes. More 
discussions and better communication may be insufficient to achieve substantial 
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improvements in patient outcomes such as distress, psychological symptoms, and quality of 
life. 
A number of these reviews included studies of interventions in which professionals used 
results of screening to structure discussions with patients that would otherwise be occurring, 
but without triaging, i.e., a score on a screening instrument did not determine whether the 
discussions would be held and which patients would be potentially offered services. This 
practice does not meet the formal definition of screening, but it is consistent with practices 
already implemented in some countries such as the Netherlands [3]. However, international 
guidelines indicate that a positive screen for distress should determine whether patients are 
offered a discussion. In countries such as the Netherlands, imposition of this guideline would 
require restricting the existing offering of discussions with professionals to patients who 
screen positive. While many patients who have significant unmet and addressable needs 
screen positive for distress, not all do. Many patients may have focal, remediable problems 
without registering general distress above a pre-set cutpoint. Furthermore, as seen in 
recruitment to clinical trials for evaluating interventions for distress, most patients who enroll 
do not have clinically significant distress, and so there would be a dilemma of whether they 
could still access such services. One of the unintended consequences of introduction of 
screening is that it could involve rationing of services and restricting of services to many 
patients who are currently accessing them. 
A critical commentary on our systematic review [5] was solicited from some leading 
proponents of screening for distress, Barry Bultz and Linda Carlson [22]. We were given the 
opportunity to reply [23], creating one of the few debates that has occurred concerning the 
merits of screening for distress. Bultz and Carlson [22] criticized the conclusion of our review 
because it 
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contravenes recommendations to screen broadly, which are based on prevalence 
studies demonstrating that patients experience distress in all of the physical, 
psychosocial and practical domains, with a real interplay among domains. 
Recommendations of professional organizations about screening for distress have not 
followed established processes for developing systematic review–based consensus practice 
guidelines. It has been well-documented that practice guidelines from professional 
organizations are often biased and not evidence-based, particularly when for they are 
proposals for medical procedures that would require their members’ services [24,25]. Criteria 
have been established for evaluating the processes generating guidelines [26,27]. Judged by 
those criteria, the process for developing recommendations for routine screening have been 
notably lacking of systematic review of the literature;  transparency; composition of guidelines 
committee including formal involvement of patients, frontline clinician, and other key 
stakeholders; indicating of strength of evidence; articulation of guidelines in terms of strength 
of evidence; and external review. 
Bultz and Carlson [22] also criticized us for adopting a narrow definition of distress and 
cite the broad definition of the National Comprehensive Cancer Network (NCCN) of distress 
as 
“a multifactorial unpleasant emotional experience of a psychological (cognitive, 
behavioral, emotional), social and/or spiritual nature that may interfere with the ability 
to cope with cancer, its physical symptoms and its treatment.”   
They further noted “Assessment recommendations include screening for specific problems 
which exacerbate distress in the physical, psychosocial and practical domains.” In their own 
screening studies, Bultz and Carlson have operationalized as the simultaneous administration 
of different “screening tools” for general distress, anxiety, depression, suicidal ideation, pain, 
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fatigue, nutrition and weight, as well as concerns about accommodations for caregivers, 
transportation, parking, drug coverage, work and school, finances, and groceries [28]. 
This broadened definition poses problems for establishing criteria for evaluating the 
efficacy and cost-effectiveness of screening.  In our reply [23], we noted that there are models 
for evaluating screening with multiple targets, and notably the United States Preventive 
Services Task Force (USPSTF) [16], which evaluates evidence on preventive services 
interventions in primary care. 
Primary care physicians are encouraged to screen for many different conditions, and 
many of them have psychosocial components (e.g., depression, intimate partner 
violence, alcohol abuse, smoking). Importantly, evidence for each of these screening 
interventions is evaluated separately. Otherwise, it would be impossible to determine 
which screening programs are beneficial and cost-effective. The same logic applies to 
psychosocial care in cancer settings. It may be the case that patients would benefit from 
being screening for many different problems. However, consistent with general principles 
of testing screening programs and expectations that scarce health care resources must 
be used wisely to be used effectively…[A]  scattershot approach to screening, without 
any evidence of what works and what doesn’t work, does not serve the best interests of 
patients. Appropriate targets for screening are medical problems for which screening can 
lead to effective intervention. Issues like parking or insurance problems can be identified 
by simply asking patients, but do not constitute screening. Once appropriate targets for 
screening are identified, the parameters for testing the screening program must be 
carefully considered. 
Even without broadening, the term “distress” lacks a direct equivalent in many 
languages. The broadened conception of distress may prove difficult to operationalize and 
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implement outside of Anglo-American contexts, particularly where there has not been 
significant linguistic migration of the term, not only to clinicians but among patients [29-31]. 
Clinicians elsewhere soon discover that patients are bewildered by requests to complete a 
distress thermometer and that their responses are unreliable. Even with native English 
speakers, it is unclear to patients whether their responses to the distress thermometer should 
take into account physical symptoms and side effects of treatment or practical problems that 
patients do not assume can be solved within oncology services. Moreover, clinicians, 
particularly those with mental health backgrounds, are inclined to interpret the registering of 
such symptoms in terms of psychological morbidity. 
The Validity of Screening Instruments and Cutpoints 
Most guidelines indicate that screening for distress should make use of validated 
instruments with published cutpoints to identify distressed patients. Broadening of the rubric of 
distress has contributed to confusion as to what constitutes the gold standard for validating 
the performance of screening instruments and therefore how an optimal cutpoint should be 
set. There has been some effort to validate distress thermometers against problem lists and 
measures of unmet need. However, this effort is handicapped by measures of unmet need 
lacking psychometric development [32], with specific items greatly differing in their nature, 
clinical significance, and requirements for the resolution of the problem indicated by the item. 
Many tertiary comprehensive cancer centers draw from a wide geographic area, and so 
practical problems are commonly endorsed, such as transportation and parking, and housing 
for caregivers who accompany cancer patients to treatment. Any scale that combines items 
reflecting these problems with items indicating fatigue, inadequately treated pain or existential 
issues faces complex questions of weighing and prioritizing of these problems that will 
frustrate efforts at establishing basic psychometric characteristics [33]. 
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Screening instruments are most often validated in terms of their performance as 
measures of emotional distress [34,35].  A number of screening instruments are available, but 
the most commonly recommended are the single item Distress Thermometer (DT) and, at 
least outside North America, the Hospital Anxiety and Depression Scale (HADS). The HADS 
is the most commonly used instrument  to validate whether the shorter distress thermometer 
is sufficient as replacement for longer questionnaires and with what cutpoints.  Yet both the 
DT and HADS have inexplicable wide variations in the cutpoints recommended in the 
research literature.  
Mitchell’s [35] comprehensive review of 19 studies analyzing the performance of the 
DT concluded that modest overall accuracy in detecting depression or anxiety disorders.  A 
score below an established cutpoint is better at ruling out disorder than a score above a 
cutpoint is at ruling in the presence of a disorder.  Depression and anxiety disorders have 
evidence-based treatments with psychotropic medications that require formal diagnosis to 
ensure that they are being administered to the appropriate persons. The implication of 
Mitchell’s analyses are that appropriate use of the DT requires trained and credentialed staff 
for follow-up psychiatric diagnostic interviews and that the second stage interviewing will be 
inefficient in terms of identification of treatable disorder. Presumably, if such use of the DT is 
to result in improved patient outcomes, there has to be appropriate clinical resources for 
treatment and follow-up. Elsewhere, Mitchell [36] has noted 
No screening tool should be seen as an alternative to careful clinical assessment and 
management. Despite much interest in the development of short and ultra-short tools, 
data on validation and implementation are currently incomplete. Nevertheless, short 
methods seem to be at least as successful as the HADS, although substantially more 
efficient and hence more acceptable, and therefore may be a suitable initial method of 
assessment in busy clinical settings.  
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Mitchell’s conclusions are valid, but his analyses overlook a serious problem in validation 
studies of the DT and in efforts to integrate them. In his analyses, Mitchell simply accepted the 
cutpoints that particular validation studies had obtained, with notable variation across studies. 
He committed the fallacy of assuming that for screening purposes, it is instruments that are 
being validated, not cutpoints. The reverse is true. It actually makes no sense to summarize a 
body of literature as offering evidence for the validity of screening, when the studies that are 
integrated relied on different cut points. Worse, without too many exceptions, these studies 
typically provide exaggerated estimates of the performance of the DT because they allowed 
the cutpoints the DT to freely vary or tested multiple cutpoints and chose the one that makes 
the DT looked most favorable. In either instance, such studies capitalize on chance and adapt 
to idiosyncratic characteristics of convenience samples or simple sampling error, reducing the 
generalizability. The practical clinical implication is that clinicians and program developers 
cannot expect that cutoffs for the DT available literature will be the most efficient for their 
purposes. 
A number of reviews have evaluated the Hospital Anxiety and Depression Scale (HADS) 
as providing measures of anxiety and depression symptoms, as a means of screening for 
anxiety depressive disorders, and as a means of validating the DT as a short measure of 
distress against the longer one [34,35]. The same caveats apply about not using a screening 
instrument to make diagnoses from which treatment decisions will be made, but rather to rely 
on results obtained with the screening instrument as the first step in a two-step process in 
which positive screens of follow-up with an interview. However, there are more serious 
problems with the use of the HADS as a screening instrument, particularly crossculturally. 
Translations do not address formidable challenges to ensuring the resulting instrument 
adequately reproduces the content and structure of the original HADS [37]. The HADS has 
inexplicable variations in recommendations for optimal cutpoints, even using the original  
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English version [38]. Applications of various factor analytic techniques frequently fail to identify 
the intended separate anxiety and depression subscales, and results of factor analyses are 
highly dependent on the particular method chosen and the sample. At best, the items of the 
HADS converge on a single general distress factor. Examination of the content and response 
keys of the HADS reveal the source of the problems. British colloquial English of the 1950s 
was used in item construction, with an avoidance of description of psychiatric symptoms. In 
order to avoid patients ignoring item content and falling into a particular response set, 
developers of the HADS allowed response keys vary in content and be reversed from item to 
item in ways that patients will undoubtedly miss. We examined translations of the HADS and 
found evidence that translators either ignored these issues or improvised, calling into question 
the validity of the translations [37]. Overall, there is little to recommend the HADS either in its 
originally intended use in assessing or screening for depression and anxiety or as a measure 
of general distress, particularly in translation [38]. 
Finally, almost all validation of distress measures in oncology settings provide 
exaggerated estimates of their performance, because studies fail to exclude patients who are 
already known to have a psychiatric disorder or to already receiving mental health or 
psychosocial services [39]. Think of it: would we accept validations of mammography that 
failed to exclude patients with breast cancer or in treatment for breast cancer? In the few 
studies that exclude patients already receiving psychotropic medication, conventional 
screening instruments are found to be much less efficient in detecting otherwise missed 
psychiatric disorder [40]. 
Although recommendations for screening commonly recommend use of validated 
instruments with established cutpoints, evidence concerning “validation” is often weak and 
inconsistent. Revalidation of specific cutpoints in a particular setting can prove an ambitious 
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undertaking. Undoubtedly, to the extent to which screening is sustained in clinical settings, it is 
often informal, with choices of particular cutpoints intuitive and based on face validity. 
Clinical Epidemiology and the Rationale for Screening. 
 
Although less decisive than evidence from RCTs showing that screening improves 
patient outcomes, a variety of clinical epidemiological data can be referenced in making 
judgments about implementing routine screening of cancer patients for distress. Such data 
include comparative estimates of the rates of psychological symptomatology and diagnosable 
psychiatric disorder among cancer patients versus other medical populations; the trajectories 
of distress among cancer patients in routine care; the extent to which cancer patients actually 
prefer unmet needs uncovered in screening to be met within cancer care or by referral; and 
the extent to which patients who were screened and offered services actually receive those 
services. These data can either encourage implementation of screening or serve to raise 
questions whether screening is likely to provide substantial, clinically significant improvements 
in patient outcomes. 
Studies of cancer patients using validated measures of psychological symptoms and 
psychiatric diagnoses based on validated semi structured interview [41] reveal comparable 
rates of symptoms and mental health problems to what is found in other specialty in general 
medical settings, including primary care [40,42]. Discussions of the need for implementing 
routine screening of cancer patients for distress typically assume high rates of symptoms and 
psychiatric disorder relative to other populations. This assumption may warrant a reevaluation. 
Much of the heightened distress reported by cancer patients is self-limiting or resolves 
within routine cancer care without specialty psychosocial or mental health services [43,44]. 
The declining trajectory of distress is such that in large-scale screening studies [28,45] the 
overall rate of decline across groups, including control groups is substantially greater than any 
difference among interventions of varying intensity.  Longitudinal observational studies of 
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patients who have been screened for distressed tend to assume that decreases in distress are 
attributable to the effects of screening, but this may not be the case. 
A substantial proportion of the cancer patients indicating unmet needs do not wish to 
receive services within the context of cancer care [46, 47]. When asked, cancer patients 
variously indicate that they are already receiving services; believe they can solve the 
problems themselves; that concentrating on the substantial demands of treating their physical 
illness takes precedence over receiving psychosocial and supportive services; or simply that 
the services being offered to them are not needed, timely, or what they preferred [47,48]. 
Endorsements of problems on checklist do not necessarily represent meetable unmet needs 
in rates of endorsements may be poor estimates of the extent to which patients will accept 
services as a result of screening. 
Only a minority of cancer patients who screen positive for distress subsequently receive 
services [45,49] and the limited available data suggest that screening is not a cost-effective 
way of getting cancer patients into services [49]. Presumably, the key mechanism by which 
routine screening would improve patient outcomes is that screening would increase uptake of 
services not otherwise received. There is a paucity of data that screening actually increases 
uptake of services. Yet such data should be considered crucial for evaluating prospects of 
screening for distress being likely to improve patient outcomes. 
Screening for Distress Versus Alternative Use of Resources  
Without adequate resources, the process of screening can degenerate into patients 
completing a screening instrument that is simply lost or placed in a paper folder or electronic 
record without further action. Alternatively, patients screening positive will be given referrals 
and sent off with no follow up as to the completion or the adequacy of the services received. 
Unless care is taken in implementing touchscreen screening for distress, interacting with a 
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touchscreen can become just another barrier to patients having ready face-to-face contact 
with peer and professional resources. 
The large literature concerning improving care for depression suggests that to be 
effective, screening requires substantial resources including screening personnel and 
interviewers, staffing for making and rescheduling appointments and following up with 
patients, as well as accessible and affordable services matching patient needs and 
preferences. These conditions in turn require a coordinated, well resourced system with 
aligned incentives and an information system capable of fostering communication among 
diverse and potentially dispersed providers and with the patient. The obvious question 
becomes whether screening adds anything to such an infusion and organization of resources 
in terms of better patient outcomes.  
Alternatives to screening include enhanced support, access to services, and follow up 
for patients already known to be distressed or socially disadvantaged [50], navigators or 
advocates for the socially disadvantaged, or simply providing ready opportunities for patients 
to discuss unmet needs with professional and peer counselors regardless of level of distress.  
Conclusion 
The absence of evidence that screening for distress improves patient outcomes is not 
the same as evidence that screening does not improve outcomes. However, the burden of 
proof lies with those who propose medical interventions like screening, not those who remain 
unconvinced of its benefits relative to alternative uses of the same resources.  
Improvement in the outcome of patients who screen positive typically depends on 
referral to supportive services. In many medical settings, referrals are notoriously uncertain in 
their outcomes, and the fate of referrals—whether patients actually complete them and obtain 
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adequate services—is information that is typically not obtained; thus, the term “black hole of 
referrals” is applied in many settings to indicate that staff do not know what happens to 
referrals. It is known that low income and otherwise socially disadvantaged persons are much 
less likely to complete a referral. Any system depending on referrals needs to have features 
built in to make the extra effort for disadvantaged patients or else it will increase health 
disparities in receipt of services.  
Regardless of the uniformity assumed by international guidelines, different cultures and 
different health systems will require radical differences if they go forward in the translation of 
guidelines into practice. Similarly, these cultural health system differences will also mean that 
potential unintended consequences of introducing screening will be different, as well as the 
pressing alternative use that the resources consumed by screening could be put. 
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